These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1724894)

  • 21. Cystic fibrosis transmembrane conductance regulator (CFTR).
    Higgins CF
    Br Med Bull; 1992 Oct; 48(4):754-65. PubMed ID: 1281034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What we know and what we do not know about cystic fibrosis transmembrane conductance regulator.
    Ma J; Davis PB
    Clin Chest Med; 1998 Sep; 19(3):459-71, v-vi. PubMed ID: 9759549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cystic fibrosis gene expression is not correlated with rectifying Cl- channels.
    Ward CL; Krouse ME; Gruenert DC; Kopito RR; Wine JJ
    Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5277-81. PubMed ID: 1711224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cystic fibrosis, the CFTR, and rectifying Cl- channels.
    Wine JJ; Brayden DJ; Hagiwara G; Krouse ME; Law TC; Müller UJ; Solc CK; Ward CL; Widdicombe JH; Xia Y
    Adv Exp Med Biol; 1991; 290():253-69; discussion 269-72. PubMed ID: 1719763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclic AMP-dependent protein kinase activation of cystic fibrosis transmembrane conductance regulator chloride channels in planar lipid bilayers.
    Tilly BC; Winter MC; Ostedgaard LS; O'Riordan C; Smith AE; Welsh MJ
    J Biol Chem; 1992 May; 267(14):9470-3. PubMed ID: 1374403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of plasma membrane recycling by CFTR.
    Bradbury NA; Jilling T; Berta G; Sorscher EJ; Bridges RJ; Kirk KL
    Science; 1992 Apr; 256(5056):530-2. PubMed ID: 1373908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cystic fibrosis. Sickly channels in mild disease.
    Miller C
    Nature; 1993 Mar; 362(6416):106. PubMed ID: 7680767
    [No Abstract]   [Full Text] [Related]  

  • 28. Relationship of a non-cystic fibrosis transmembrane conductance regulator-mediated chloride conductance to organ-level disease in Cftr(-/-) mice.
    Clarke LL; Grubb BR; Yankaskas JR; Cotton CU; McKenzie A; Boucher RC
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):479-83. PubMed ID: 7507247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene transfer to freshly isolated human respiratory epithelial cells in vitro using a replication-deficient adenovirus containing the human cystic fibrosis transmembrane conductance regulator cDNA.
    Rosenfeld MA; Chu CS; Seth P; Danel C; Banks T; Yoneyama K; Yoshimura K; Crystal RG
    Hum Gene Ther; 1994 Mar; 5(3):331-42. PubMed ID: 7517189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cl- channels in CF: lack of activation by protein kinase C and cAMP-dependent protein kinase.
    Hwang TC; Lu L; Zeitlin PL; Gruenert DC; Huganir R; Guggino WB
    Science; 1989 Jun; 244(4910):1351-3. PubMed ID: 2472005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cystic fibrosis: current concepts.
    Abrons HL
    W V Med J; 1993 Jun; 89(6):236-40. PubMed ID: 7686701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphorylation-regulated Cl- channel in CHO cells stably expressing the cystic fibrosis gene.
    Tabcharani JA; Chang XB; Riordan JR; Hanrahan JW
    Nature; 1991 Aug; 352(6336):628-31. PubMed ID: 1714039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CFTR and outward rectifying chloride channels are distinct proteins with a regulatory relationship.
    Gabriel SE; Clarke LL; Boucher RC; Stutts MJ
    Nature; 1993 May; 363(6426):263-8. PubMed ID: 7683773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer.
    Drumm ML; Pope HA; Cliff WH; Rommens JM; Marvin SA; Tsui LC; Collins FS; Frizzell RA; Wilson JM
    Cell; 1990 Sep; 62(6):1227-33. PubMed ID: 1698126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cystic fibrosis transmembrane regulator is present and functional in endosomes. Role as a determinant of endosomal pH.
    Lukacs GL; Chang XB; Kartner N; Rotstein OD; Riordan JR; Grinstein S
    J Biol Chem; 1992 Jul; 267(21):14568-72. PubMed ID: 1378835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cystic fibrosis and the use of pharmacogenomics to determine surrogate endpoints for drug discovery.
    Eidelman O; Zhang J; Srivastava M; Pollard HB
    Am J Pharmacogenomics; 2001; 1(3):223-38. PubMed ID: 12083969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis.
    Knowles MR; Paradiso AM; Boucher RC
    Hum Gene Ther; 1995 Apr; 6(4):445-55. PubMed ID: 7542031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of an abundant alternatively spliced form of the cystic fibrosis transmembrane conductance regulator (CFTR) gene is not associated with a cAMP-activated chloride conductance.
    Strong TV; Wilkinson DJ; Mansoura MK; Devor DC; Henze K; Yang Y; Wilson JM; Cohn JA; Dawson DC; Frizzell RA
    Hum Mol Genet; 1993 Mar; 2(3):225-30. PubMed ID: 7684641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation.
    Dalemans W; Barbry P; Champigny G; Jallat S; Dott K; Dreyer D; Crystal RG; Pavirani A; Lecocq JP; Lazdunski M
    Nature; 1991 Dec 19-26; 354(6354):526-8. PubMed ID: 1722027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes.
    Drumm ML; Wilkinson DJ; Smit LS; Worrell RT; Strong TV; Frizzell RA; Dawson DC; Collins FS
    Science; 1991 Dec; 254(5039):1797-9. PubMed ID: 1722350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.